Immunomodulatory and antitumour effects of abnormal Savda Munziq on S180 tumour-bearing miceAiniwaer Aikemu, Nicholas Moore|BMC Complementary and Alternative Medicine|2012Cited by 22
The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosisHelmut Butzkueven, Meritxell Sabidó, Jens Kühle et al.|Current Medical Research and Opinion|2023Cited by 7
Harmonized Data Quality Indicators Maintain Data Quality in Long-Term Safety Studies Using Multiple Sclerosis Registries/Data Sources: Experience from the CLARION StudyJan Hillert, Meritxell Sabidó, Helmut Butzkueven et al.|Clinical Epidemiology|2024Cited by 4